These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8908298)

  • 1. Insight into antibody combining sites using nuclear magnetic resonance and spin label haptens.
    McConnell HM; Martinez-Yamout M
    Adv Protein Chem; 1996; 49():135-48. PubMed ID: 8908298
    [No Abstract]   [Full Text] [Related]  

  • 2. Structural and kinetic studies of the Fab fragment of a monoclonal anti-spin label antibody by nuclear magnetic resonance.
    Theriault TP; Leahy DJ; Levitt M; McConnell HM; Rule GS
    J Mol Biol; 1991 Sep; 221(1):257-70. PubMed ID: 1920409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural convergence in the active sites of a family of catalytic antibodies.
    Charbonnier JB; Golinelli-Pimpaneau B; Gigant B; Tawfik DS; Chap R; Schindler DG; Kim SH; Green BS; Eshhar Z; Knossow M
    Science; 1997 Feb; 275(5303):1140-2. PubMed ID: 9027317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the complex of a catalytic antibody Fab fragment with a transition state analog: structural similarities in esterase-like catalytic antibodies.
    Charbonnier JB; Carpenter E; Gigant B; Golinelli-Pimpaneau B; Eshhar Z; Green BS; Knossow M
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11721-5. PubMed ID: 8524836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How the anti-(metal chelate) antibody CHA255 is specific for the metal ion of its antigen: X-ray structures for two Fab'/hapten complexes with different metals in the chelate.
    Love RA; Villafranca JE; Aust RM; Nakamura KK; Jue RA; Major JG; Radhakrishnan R; Butler WF
    Biochemistry; 1993 Oct; 32(41):10950-9. PubMed ID: 8218161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and specificity of the anti-digoxin antibody 40-50.
    Jeffrey PD; Schildbach JF; Chang CY; Kussie PH; Margolies MN; Sheriff S
    J Mol Biol; 1995 Apr; 248(2):344-60. PubMed ID: 7739045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spin-spin interaction between iminoxyl radicals localised in antibody combining sites.
    Käiväräinen AI; Nezlin RS; Volkenstein MV
    FEBS Lett; 1973 Sep; 35(2):306-8. PubMed ID: 4355320
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of the crystallographic structures of two catalytic antibodies with esterase activity.
    Buchbinder JL; Stephenson RC; Scanlan TS; Fletterick RJ
    J Mol Biol; 1998 Oct; 282(5):1033-41. PubMed ID: 9753552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonaromatic amino acids in the combining site region of a monoclonal anti-spin-label antibody.
    Frey T; Anglister J; McConnell HM
    Biochemistry; 1984 Dec; 23(26):6470-3. PubMed ID: 6529564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of shape complementarity and catalytic efficiency from a primordial antibody template.
    Xu J; Deng Q; Chen J; Houk KN; Bartek J; Hilvert D; Wilson IA
    Science; 1999 Dec; 286(5448):2345-8. PubMed ID: 10600746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural evidence for a programmed general base in the active site of a catalytic antibody.
    Golinelli-Pimpaneau B; Goncalves O; Dintinger T; Blanchard D; Knossow M; Tellier C
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9892-5. PubMed ID: 10963661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody--hapten interactions in solution.
    Dwek RA; Jones R; Marsh D; McLaughlin AC; Press EM; Price NC; White AI
    Philos Trans R Soc Lond B Biol Sci; 1975 Nov; 272(915):53-74. PubMed ID: 1818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance and fluorescence studies of the binding of O-carboxymethyl-4-methylumbelliferone to its specific antibody.
    Harina BM; Bothner-By AA; Gill TJ
    Biochemistry; 1977 Oct; 16(20):4504-12. PubMed ID: 562182
    [No Abstract]   [Full Text] [Related]  

  • 14. NMR observation of interactions in the combining site region of an antibody using a spin-labeled peptide antigen and NOESY difference spectroscopy.
    Scherf T; Hiller R; Anglister J
    FASEB J; 1995 Jan; 9(1):120-6. PubMed ID: 7821751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural aspects of antibodies and antibody-antigen complexes.
    Wilson IA; Stanfield RL; Rini JM; Arevalo JH; Schulze-Gahmen U; Fremont DH; Stura EA
    Ciba Found Symp; 1991; 159():13-28; discussion 28-39. PubMed ID: 1959445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of human germline antibody 3-23/B3.
    Malia TJ; Obmolova G; Almagro JC; Gilliland GL; Teplyakov A
    Mol Immunol; 2011 Jul; 48(12-13):1586-8. PubMed ID: 21605907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of saccharide haptens with myeloma proteins. A 270-MHz proton nuclear magnetic resonance study.
    Gettins P; Boyd J; Glaudemans CP; Potter M; Dwek RA
    Biochemistry; 1981 Dec; 20(26):7463-9. PubMed ID: 6275881
    [No Abstract]   [Full Text] [Related]  

  • 18. Interactions of the lanthanide- and hapten-binding sites in the Fv fragment from the myeloma protein MOPC 315.
    Dwek RA; Givol D; Jones R; McLaughlin AC; Wain-Hobson S; White AI; Wright C
    Biochem J; 1976 Apr; 155(1):37-53. PubMed ID: 7239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular dynamics force probe simulations of antibody/antigen unbinding: entropic control and nonadditivity of unbinding forces.
    Heymann B; Grubmüller H
    Biophys J; 2001 Sep; 81(3):1295-313. PubMed ID: 11509346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spin-label approach to conformational properties of immunoglobulins.
    Käiväräinen AI; Nezlin RS
    Immunochemistry; 1976 Dec; 13(12):1001-8. PubMed ID: 797657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.